Note: SUPRAX® is generally effective in the eradication of S. pyogenes from the nasopharynx; however, data establishing the efficacy of SUPRAX® in the subsequent prevention of rheumatic fever are not available.
Study conducted at Childrens Mercy Hospital, Kansas City. Omnicef (cefdinir) is a registered trademark of Warner-Lambert Company.
*In vitro susceptibility does not imply in vivo efficacy.
a Reported as 100% in study.